What are the Challenges in Targeting Fusion Proteins?
One of the main challenges in targeting fusion proteins is the development of drug resistance. Cancer cells can develop mutations that render targeted therapies ineffective. Additionally, some fusion proteins are difficult to target due to their structural complexity or lack of suitable binding sites for drugs. Overcoming these challenges requires ongoing research and the development of novel therapeutic strategies.
